申请人:Entrada Therapeutics, Inc.
公开号:US10626147B2
公开(公告)日:2020-04-21
Disclosed herein are compounds having activity as cell penetrating peptides. In some examples, the compounds can comprise a cell penetrating peptide moiety and a cargo moiety. The cargo moiety can comprise one or more detectable moieties, one or more therapeutic moieties, one or more targeting moieties, or any combination thereof. In some examples, the cell penetrating peptide moiety is cyclic. In some examples, the cell penetrating peptide moiety and cargo moiety together are cyclic. In some examples, the cell penetrating peptide moiety is cyclic and the cargo moiety is appended to the cyclic cell penetrating peptide moiety structure. In some examples, the cargo moiety is cyclic and the cell penetrating peptide moiety is cyclic, and together they form a fused bicyclic system.
本文公开了具有细胞穿透肽活性的化合物。在一些例子中,这些化合物可以包括细胞穿透肽分子和货物分子。货物分子可以包括一个或多个可检测分子、一个或多个治疗分子、一个或多个靶向分子或它们的任意组合。在某些例子中,细胞穿透肽分子是环状的。在某些例子中,细胞穿透肽分子和货物分子是环状的。在某些例子中,细胞渗透肽分子是环状的,而货物分子被附加到环状细胞渗透肽分子结构上。在某些例子中,货物分子是环状的,而细胞穿透肽分子是环状的,它们共同形成一个融合的双环系统。